Expression of Versican Isoform V3 in the Absence of Ascorbate Improves Elastogenesis in Engineered Vascular Constructs
- 1 February 2010
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 16 (2) , 501-512
Abstract
A promising method to fabricate tissue-engineered blood vessels is to have cells synthesize the supportive extracellular matrix scaffold of the tissue-engineered blood vessel; however, a shortcoming of this method has been limited elastogenesis. Previously, we found that arterial smooth muscle cells (ASMCs) produced significant quantities of elastin when transduced with splice variant 3 of the proteoglycan versican (V3). In this study, we assessed whether elastogenesis and the structural properties of entirely cell-derived engineered vascular constructs could be improved by the incorporation of V3-transduced rat ASMCs. After 18 weeks of culture, V3 constructs had more tropoelastin, more elastin crosslinks, higher burst strengths, greater elasticity, and thicker collagen fiber bundles compared with empty-vector controls. The expression of elastin and elastin-associated proteins was increased in V3 and control ASMC monolayer cultures when ascorbic acid, which promotes collagen synthesis and inhibits elastogenesis, was removed from the medium. Engineered vascular constructs with ascorbate withdrawn for 14 weeks, after an initial 4-week exposure to ascorbate, exhibited increased elastin, desmosine content, elasticity, and burst strength compared with constructs exposed continuously to ascorbate. Our results show that V3 coupled with limited exposure to ascorbate promotes elastogenesis and improves the structural and functional properties of engineered vascular constructs.Keywords
This publication has 46 references indexed in Scilit:
- Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary arteryBiomaterials, 2009
- Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysisProceedings of the National Academy of Sciences, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- Applying elastic fibre biology in vascular tissue engineeringPhilosophical Transactions of the Royal Society B: Biological Sciences, 2007
- Mechanical Properties and Compositions of Tissue Engineered and Native ArteriesAnnals of Biomedical Engineering, 2007
- Does PGA external stenting reduce compliance mismatch in venous grafts?BioMedical Engineering OnLine, 2007
- Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxaHuman Molecular Genetics, 2006
- Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: Characterization and influence on osteoblastic cellsJournal of Biomedical Materials Research Part A, 2006
- Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a reviewJournal of Artificial Organs, 2003
- Effect of varying amounts of ascorbate on collagen, elastin and lysyl oxidase synthesis in aortic smooth muscle cell culturesBiochimica et Biophysica Acta (BBA) - General Subjects, 1984